Medline is preparing to test investor appetite for one of the largest healthcare offerings in years, seeking a public ...

The spotlight is on crown jewels HBO, studios, the Warner Bros. film vault and DC Comics – but the fate of Warner Bros.

"I was talking to as many people as I could and taking money from anyone who would give it to me," Hinge CEO Justin McLeod ...

Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

Lumexa Imaging's shares rose marginally in their Nasdaq debut on Thursday, valuing the provider of diagnostic imaging ...

Hinge founder Justin McLeod is stepping down as CEO of the popular dating app to launch a new AI-powered dating service ...

The startup's new tech could compete with Big Tech's health AI projects from heavyweights like Alphabet and OpenAI.

Organogenesis is selling for ~1X its guided forward revenues despite a significant recent favorable CMS product coverage ...

Among 27 analysts, MercadoLibre has a median target price of $2,842 per share, which implies 42% upside from its current ...

With GST changes creating both winners and laggards, insurers are now looking to the Insurance Amendment Bill as the next major trigger for sector-wide re-rating ...